• 250K

Information updates

Shortage of venom immunotherapy products: honey bee, paper wasp and yellow jacket - Supply update from Stallergenes Greer

13 April 2018: 

As communicated in March 2018, events overseas have impacted the ability of Stallergenes Greer to supply venom immunotherapy products to Australia and New Zealand.  The first direct shipment of venom products from JHS to Australia has now arrived, and ASCIA has received the following advice:

Honey Bee venom

  • Hymenoptera Honey Bee venom will be available again in Australia towards the end of week commencing 16 April 2018.

Please note: only orders for the “Hymenoptera” brand of honey bee venom will be processed at this time. Customers with backorders for the “Albey” brand honey bee venom are advised to contact their wholesaler and request these orders be changed to “Hymenoptera” or cancelled as appropriate. For any assistance, contact the Stallergenes Greer Customer Service team on 1800 824 166 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

  • In New Zealand there is sufficient Albey Honey Bee venom stock to meet demand over the next 6 months.

Paper Wasp venom

  • Paper Wasp venom is currently out of stock in Australia. Stallergenes Greer is endeavouring to confirm the date of the next available shipment of Paper Wasp venom and will provide updates as soon as possible.
  • In NZ there is sufficient Albey Paper Wasp venom stock to meet demand over the next 3 months.

Yellow Jacket venom

  • Yellow Jacket venom is NOT out of stock in either Australia or New Zealand, however the remaining Albey Yellow Jacket venom stock is short-dated (expiry May 2018). Hymenoptera Yellow Jacket venom will be available from May 2018. 

For any further assistance, please contact Stallergenes Greer according to the information set out below:

  • For orders or status of orders, please contact the Customer Service team on 1800 824 166 or email This email address is being protected from spambots. You need JavaScript enabled to view it.
    • For medical information enquiries, please contact Dr Martin Rees (APAC Regional Medical Director) on This email address is being protected from spambots. You need JavaScript enabled to view it.
    • To report adverse events, please contact Stallergenes Greer on 1800 824 166

Stallergenes Greer understands the impact of this shortage on both patients and prescribers, and are committed to ensuring reliable supply of these important products into Australia and New Zealand on an ongoing basis.

Further updates will be provided to the ASCIA community as soon as more information is available.

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.